CONMED CORPORATION (CNMD) Return on equity 2016–2025
CONMED CORPORATION (CNMD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
4.6%FY2025 · since FY2016: 2.5% → 4.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.6% | -9.2 pp |
| FY2024 | 13.8% | +6.0 pp |
| FY2023 | 7.7% | +18.5 pp |
| FY2022 | -10.8% | -18.8 pp |
| FY2021 | 8.0% | +6.6 pp |
| FY2020 | 1.3% | -2.7 pp |
| FY2019 | 4.0% | -2.1 pp |
| FY2018 | 6.2% | -2.6 pp |
| FY2017 | 8.8% | +6.3 pp |
| FY2016 | 2.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice